Tumor necrosis factor-alpha and interleukin-6 are differently expressed by fresh human cancerous ovarian tissue and primary cell lines

European Cytokine Network

Volumn 9, Issue 2, 1998, Pages 171-179

  Glezerman, Marek ^a,b   Mazot, Moshe ^c   Maymon, Eli ^a   Piura, Benjamin ^a   Prinsloo, Isebrand ^a   Benharroch, Daniel ^a   Yanai Inbar, Ilana ^a   Huleihel, Mahmoud ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c NONE

Author keywords

Cytokines; Human ovarian tissues; Interleukin 6 (IL 6); Tumor necrosis factor alpha (TNF )

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; POLYCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL STIMULATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; OVARY CARCINOMA; OVARY CELL; SUPERNATANT;

CELL LINE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; KINETICS; OVARIAN NEOPLASMS; REFERENCE VALUES; TUMOR NECROSIS FACTOR-ALPHA;

ORYCTOLAGUS CUNICULUS;

EID: 0031840717     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Adashi E Y. 1990. The potential relevance of cytokines to ovarian physiology: the emerging role of resident ovarian cells of the white blood cell series. (Review) Endocr. Rev. 11: 454.
2. Rao B R, Slotman B J. 1991. Endocrine factors in common epithelial ovarian cancer. (Review) Endocr. Rev. 12: 14.
3. Hirano T, Akira S, Taga T, Kishimoto T. 1990. Biological and clinical aspects of interleukin-6. (Review) Immunol. Today 11: 443.
4. Akira S, Hirano T, Taga T, Kishimoto T. 1990. Biology of multifunctional cytokines: IL-6 and related molecules (IL-1 and TNF). FASEB J. 4: 2860.
5. Balkwil F R, Burke F. 1989. The cytokine network. (Review) Immunol. Today 10: 299.
6. Bont L, Ben-Efraim S. 1993. Involvement of inflammatory mediators in macrophage antitumor activity. (Review) J. Leuk. Biol. 54: 613.
7. Arbeit J M. 1989. Molecules, cancer, and the surgeon. Ann. Surg. 212: 3.
8. Kawano M, Hirano T, Matsuda T, Taga T, Horri Y, Iwato K, Asaoku H, Tang B, Tanabe O, Tanaka H, Kuramoto A, Kishimoto T. 1988. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 332: 83.
9. Freeman G J, Freedman A S, Rabinowe S N, Segil J M, Horowitz J, Rosen K, Whitman J F, Nadler L M. 1989. Interleukin-6 gene expression in normal and neoplastic B cells. J. Clin. Invest. 83: 1512.
10. Yee C, Biondi A, Wang X H, Iscove N N, de Sousa J, Aarden L A, Wong G G, Clark S C, Messner H A, Winden M D. 1989. A possible autocrine role for interleukin-6 in two lymphoma cell lines. Blood 74: 798.
11. Biondi A, Rossi V, Bassan R, Barbui T, Bettoni S, Sironi M, Mantovani A, Rambaldi A. 1989. Constitutive expression of the interleukin-6 gene in chronic lymphocytic leukemia. Blood 73: 1279.
12. Oster W, Cicco N A, Klein H, Hirano T, Kishimoto T, Lindemann A, Mertelsmann R H, Herrmann F. 1989. Participation of the cytokines interleukin-6 tumor necrosis factor-alpha, and interleukin-1 beta secreted by acute myelogenous leukemia blasts in autocrine and paracrine leukemia growth control. J. Clin. Invest. 84: 451.
13. Miles S A, Rezai A R, Salazar-Gonzales J F, Vander Meyden M, Stevens R H, Logan D M, Mitsuyasu R T, Taga T, Hirano T, Kishimoto T, Martinzen-Maza O. 1990. AIDS Kaposi sarcoma-derived cells produce and respond to interleukin-6. Proc. Natl. Acad. Sci. USA 87: 4068.
14. Rawle F C, Shields J, Smith S H, Iliescu V, Merkenschlager M, Beverley P C, Callard R E. 1986. B cell growth and differentiation induced by supernatants of transformed epithelial cell lines. Eur. J. Immunol. 16: 1017.
15. Miki S, Iwano M, Miki Y, Yamamoto M, Tang B, Yokokawa K, Sonoda T, Hirano T, Kishimoto T. 1989. Interleukin-6 (IL-6) function as an in vitro autocrine growth factor in renal cell carcinomas. FEBS Lett. 250: 607.
16. Watson J M, Sensintaffar J L, Berek S J, Mertinez-Maza O M. 1990. Constitutive production of interleukin-6 by ovarian cancer cell lines and by primary ovarian tumor cultures. Cancer Res. 50: 6959.
17. Kobari L, Weil D, Lemoine F M, Dubois C, Thiam D, Baillou C, Guigon M, Gorin N C, Najman A. 1990. Secretion of tumor necrosis factor-alpha by fresh human acute nonlymphoblastic leukemic cells: role in the disappearance of normal CFU-GM progenitors. Exp. Hematol. 18: 1187.
18. Hata H, Matsuzaki M, Takatsuki K. 1990. Autocrine growth by two cytokines, interleukin-6 and tumor necrosis factor-alpha in the myeloma cell line KHM-1A. Acta. Haematol. 83: 133.
19. Benharroch D, Prinsloo I, Apte R N, Yermiahu T, Geffen D B, Yanai-Inbar I, Gopas J. 1996. Interleukin-1 and tumor necrosis factor-α in the Reed-Sternberg cells of Hodgkin's disease. Correlation with clinical and morphological "inflammatory" features. Eur. Cytokine Netw. 7: 51.
20. Rubin B Y, Anderson S L, Sullivan S A, Williamson B D, Carswell E A, Old L. 1986. Nonhematopoietic cells selected for resistance to tumor necrosis factor produce tumor necrosis factor. J. Exp. Med. 164: 1350.
21. Spriggs D, Imamura K, Rodriguez C, Horiguchi J, Kufe D W. 1987. Induction of tumor necrosis factor expression and resistance in human breast tumor cell line. Proc. Natl. Acad. Sci. USA 84: 6563.
22. Huleihel M, Maymon E, Piura B, Prinsloo I, Benharroch D, Yanai-Inbar I, Glezerman M. 1997. Distinct patterns of expresion of interleukin-1 alpha and beta by human normal and cancerous ovarian tissues. Eur. Cytokine Netw. 8: 179.
23. Tacha D E, Mckinney L. 1992. Casein reduced nonspecific background staining in immunolabeling techniques. J. Histotechnol. 15: 127.
24. Aarden L A, De Groot E R, Schaap O L, Lansdorp P M. 1987. Production of hybridoma growth factor by human monocytes. Eur. J. Immunol. 17: 1411.
25. Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65: 55.
26. Flick D A, Gifford G E. 1984. Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. J. Immunol. Methods 68: 167.
27. Kooi S, Freedman R S, Rodriguez-Villanueva J, Platsoucas C D. 1993. Cytokine production by T cell lines derived from tumor-infiltrating lymphocytes from patients with ovarian carcinoma: tumor-specific immune responses and inhibition of antigen-independent cytokine production by ovarian tumor cells. Lymphokine Cytokine Res. 12: 429.
28. Erroi A, Sironi M, Chiaffarino F, Chen Z H, Mengozzi M, Mantovani A. 1989. IL-1 and IL-6 release by tumor-associated macrophages from human ovarian carcinoma. Int. J. Cancer 44: 795.
29. Tamm I, Cardinale I, Krueger J, Murphy J S, May L T, Seghal P B. 1989. Interleukin-6 decreases cell-cell association and increases motility of ductal breast carcinoma cells. J. Exp. Med. 170: 1649.
30. Burger R A, Grosen E A, Ioli G R, van Eden M E, Park M, Berman M L, Manetta A, Disaia P J, Granger G A, Gatanaga T. 1995. Spontaneous release of intereleukin-6 by primary cultures of lymphoid and tumor cell populations purified from human ovarian carcinoma. J. Interferon Cytokine Res. 15: 255.
31. Mann E A, Spiro J D, Chen L L, Kreutzer D L. 1992. Cytokine expression by head and neck squamous cell carcinomas. Am. J. Surg. 164: 567.
32. Gotlieb W H, Watson J M, Rezai A, Johnson M, Martinez-Maza O, Berek J S. 1994. Cytokine-induced modulation of tumor suppressor gene expression in ovarian cancer cells: up-regulation of p53 gene expression and induction of apoptosis by tumor necrosis factor-α. Am. J. Obstet. Gynecol. 170: 1121.
33. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M. 1991. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 353: 345.
34. Bauer J, Bauer T M, Kalb T, Taga T, Lengyel G, Hirano T, Kishimoto T, Acs G, Mayer L, Gerok W. 1989. Regulation of interleukin-6 receptor expression in human monocytes and monocyte-derived macrophages. Comparison with the expression in human hepatocytes. J. Exp. Med. 170: 1537.
35. Aderka D, Le J M, Vilcek J. 1989. IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. J. Immunol. 143: 3517.
36. Naylor M S, Stamp G W, Foulkes W D, Eccles D, Balkwill F R. 1993. Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression. J. Clin. Invest. 91: 2194.
37. Malik S T, Griffin D B, Fiers W, Balkwill F R. 1989. Paradoxal effects of tumor necrosis factor in experimental ovarian cancer. Int. J. Cancer 44: 918.
38. Takeyama H, Wakamiya N, O'Hara C, Arthur K, Niloff J, Kufe D, Sakarai K, Spriggs D. 1991. Tumor necrosis factor expression by human ovarian carcinoma in vivo. Cancer Res. 51: 4476.
39. Wu S, Boyer C M, Whitaker R S, Berchuck A, Wiener J R, Weinberg J B, Bast R C Jr. 1993. Tumor necrosis factor-alpha as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor-alpha expression. Cancer Res. 53: 1939.
40. Wu S, Meeker W A, Berchuch W A, Bast R C Jr, Boyer C M. 1994. Transfection of ovarian cancer cells with tumor necrosis factor-α (TNF-α) antisense mRNA abolishes the proliferative response to interleukin-1 (IL-1) but not TNF-α. Gynecol. Oncol. 53: 59.
41. Spriggs D, Imamura K, Rodriguez C, Horiguchi J, Kufe D W. 1987. Induction of tumor necrosis factor expression and resistance in human breast tumor cell line. Proc. Natl. Acad. Sci. USA 84: 6563.
42. Malik S, Balkwill F. 1991. Epithelial ovarian cancer: a cytokine propelled disease? Br. J. Cancer 64: 617.
43. Giavazzi R, Garofalo A, Martin-Padura I, Dejana E. 1992. Cytokine-induced adhesion molecules and tumor metastasis. Clin. Exp. Metastasis 10: 31.
44. Behammer W, Kluge M, Ruschoff J, Mannel D N. 1996. Tumor necrosis factor effects on ascites formation in an experimental tumor model. J. Interferon Cytokine Res. 16: 403.
45. Kist A, Ho A D, Rath U, Wiedenmann B, Bauer A, Schlick E, Kirshner H, Mannel D N. 1988. Decrease of natural killer activity and monokine production in peripheral blood of patients treated with recombinant tumor necrosis factor. Blood 72: 344.
46. Sancho-Tello M, Marcinkiewicz J L, Justice W M, Kimler B F, Terranova P F, Hunter V J. 1995. Reduction of tumor necrosis factor-α bioactivity by a human ovarian epithelial cancer cell line in vitro. Am. J. Obstet. Gynecol. 173: 1470.
47. Mule J J, McIntosh J K, Jablons D M, Rosenberg S A. 1990. Anti-tumor activity of recombinant interleukin-6 in mice. J. Exp. Med. 171: 629.